Evotec SE

€3.16As of Sun 8 Nov 2026, 12:00 UTC
XETRA:EVTHealthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (4.47%)
Div yield —
ROE (25.07%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.31
PE TTM —
TSR TTM (55.15%)
Mkt cap €562.4M
ROIC (18.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.74
18.27%
(96.58%)
Buy 10|12|9|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.04
0.04
0.04
0.04
16.42%
8.92%
11.15%
10.86%
Revenue€M
42.22
44.41
43.22
45.43
3.88%
10.45%
3.94%
6.46%
Peers (US$631.5M)
Cap (US$)
PE
2.114B
13.71x
137.0M
2.520x
73.93M
353.0x
Capital
TTM
5Y
10Y
Leveragex
1.120
0.512
0.475
EBIT/Intx
4.064
0.355
0.348
Own earn%
60.62
(70.63)
(72.08)
Sh yield%
41.02
22.25
22.18
Owners
Insiders/Inst%
11.37
73.17
Short interest%
5.72
SBC / revenue%
5.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
3–11
$1 testx
—
Incr. ROIC%
0